High Altitude and Chronic Obstructive Pulmonary Disease Prevalence: A Casual or Causal Correlation?;Gran altitud y prevalencia de la enfermedad pulmonar obstructiva crónica: ¿relación casual o causal?

Archivos de Bronconeumologia

Volumn 48, Issue 5, 2012, Pages 156-160

  Laniado Laborin, Rafael ^a,d   Rendón, Adrian ^b   Batiz, Fernando ^a   Alcantar Schramm, Juan Manuel ^a   Bauerle, Otto ^c  

^a UNIVERSIDAD AUTÓNOMA DE BAJA CALIFORNIA   (Mexico)

^b HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^c Centro Médico Las Américas   (Mexico)

^d Jalisco   (Mexico)

Author keywords

Altitude; Chronic obstructive pulmonary disease (COPD); Mexico; Prevalence

Indexed keywords

ADULT; ALTITUDE DISEASE; ARTICLE; BRONCHOSPIROGRAPHY; CAUSAL ATTRIBUTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; DISEASE ASSOCIATION; DISEASE SEVERITY; GENERAL PRACTITIONER; GEOGRAPHIC DISTRIBUTION; HUMAN; MALE; MEXICO; PATIENT REFERRAL; PREVALENCE; RISK FACTOR; AGE DISTRIBUTION; AGED; ALTITUDE; BIOMASS; CAUSALITY; CONTROLLED STUDY; DEMOGRAPHY; ENVIRONMENTAL EXPOSURE; FEMALE; INFORMED CONSENT; MAJOR CLINICAL STUDY; QUESTIONNAIRE; SEX DIFFERENCE; SMOKE; SMOKING HABIT;

AGED; ALTITUDE; FEMALE; HUMANS; MALE; MEXICO; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; URBAN HEALTH;

EID: 84859961675     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbres.2011.12.004     Document Type: Article

References (18)

1. Menezes A.M.B., Perez-Padilla R., Jardim J.R.B., Muiño A., Lopez M.V., Valdivia G., et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005, 366:1875-1881.
2. Caballero A., Torres-Duque C.A., Jaramillo C., Bolívar F., Sanabria F., Osorio P., et al. Prevalence of COPD in Five Colombian Cities Situated at Low, Medium, and High Altitude (PREPOCOL Study). Chest 2008, 133:343-349.
3. Mannino D.M. Looking Beyond the Cigarette in COPD [editorial]. Chest 2008, 133:333-334.
4. Laniado-Laborín R., Rendón A., Bauerle O. Chronic obstructive pulmonary disease case finding in Mexico in an at-risk population. Int J Tuberc Lung Dis 2011, 15:818-823.
5. PLATINO. Proyecto Latinoamericano de Investigación en Obstrucción Pulmonar [consultado 28 Juli 2011]. Disponible en: http://www.platino-alat.org/.
6. Celli B.R., MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004, 23:932-946.
7. Miller M.R., Hankinson J., Brusasco V., Burgos F., Casaburi R., Coates A., et al. ATS/ERS Task Force: Standardisation of lung function testing. Eur Respir J 2005, 26:319-338.
8. Torre-Bouscoulet L., Pérez-Padilla R. Grupo de trabajo del estudio PLATINO en México. Adjustment of several spirometric reference equations to a population-based sample in Mexico. Salud Publica Mex 2006, 48:466-473.
9. Global Strategy for Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease. GOLD Summary 2011 [consultado 25 Nov 2011]. Disponible en: http://www.goldcopd.org/uploads/users/files/GOLD2011_Summary.pdf.
10. Instituto Nacional de Estadística y Geografía (INEGI) [consultado 1 Mar 2011]. Disponible en: http://www.inegi.org.mx/geo/contenidos/topografia/default.aspx.
11. Welsh C.H., Wagner P.D., Reeves J.T., Lynch D., Cink T.M., Armstrong J., et al. Operation Everest: II. Spirometric and radiographic changes in acclimatized humans at simulated high altitudes. Am Rev Respir Dis 1993, 147:1239-1244.
12. Vargas M.H., Sienra-Monge J.J., Diaz-Mejia G., DeLeón-González M. Asthma and geographical altitude: an inverse relationship in Mexico. J Asthma 1999, 36:511-517.
13. Cote T.R., Stroup D.F., Dwyer D.M., Horan J.M., Peterson D.E. Chronic obstructive pulmonary disease mortality: a role for altitude. Chest 1993, 103:1194-1197.
14. Perez-Padilla R., Torre-Bouscoulet L., Muiño A., Marquez M.N., Lopez M.V., De Oca M.M., et al. Prevalence of oxygen desaturation and use of oxygen at home in adults at sea level and at moderate altitude. Eur Respir J 2006, 27:594-599.
15. Havryk A.P., Gilbert M., Burges K.R. Spirometry values in Himalayan high altitude residents (Sherpas). Respir Physiol Neurobiol 2002, 132:223-232.
16. Wood S., Norboo T., Lilly M., Yoneda K., Eldridge M. Cardiopulmonary function in high altitude residents of Ladakh. High Alt Med Biol 2003, 4:445-454.
17. Tan W.C., Sin D.D., Chapman K.R., Bourbeau J., Hernandez P., Cowie R., et al. Comparison of GOLD Stage II and the lower limits of normal for defining chronic obstructive lung disease in Canada-results from the Canadian Obstructive Lung Disease (COLD) Study. Am J Respir Crit Care Med 2010, 181:A4379.
18. Drummond M.B., Shade J.D., Berry C.E., McCormack M.C., Hansel N.N., Diette G.B., et al. Respiratory symptoms do not differ when defining COPD by fixed ratio or lower limit of normal. Am J Respir Crit Care Med 2010, 181:A4377.